Epicatechin



Compound IDCDAMM00356
Common nameEpicatechin
IUPAC name(2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
Molecular formulaC15H14O6

Experimental data

Retention time32.726
Adduct[M+H]+
Actual mz291.088
Theoretical mz291.086
Error4.46
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.84

Identifiers and class information

Inchi keyPFTAWBLQPZVEMU-UKRRQHHQSA-N
SmilesOC=1C=C(O)C2=C(OC(C3=CC=C(O)C(O)=C3)C(O)C2)C1
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)290.272
Computed dipole moment(dipole)5.174
Total solvent accessible surface area (SASA)511.529
Hydrophobic component of SASA (FOSA)66.812
Hydrophilic component of SASA (FISA)239.374
Pie component of the SASA (PISA)205.344
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)871.744
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)5.45
Free energy of solvation of dipole (dip^2/V)0.0307046
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0238238
Globularity descriptor (glob)0.862755
Predicted polarizability in cubic angstroms (QPpolrz)27.484
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.573
Predicted octanol/gas partition coefficient (QPlogPoct)19.939
Predicted water/gas partition coefficient (QPlogPw)15.563
Predicted octanol/water partition coefficient (QPlogPo/w)0.469
Predicted aqueous solubility (QPlogS)-2.616
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.474
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.732
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)53.201
Predicted brain/blood partition coefficient (QPlogBB)-1.882
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)20.76
Predicted skin permeability, log Kp (QPlogKp)-4.728
PM3 calculated ionization potential (IP(ev))8.842
PM3 calculated electron affinity (EA(eV))-0.059
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)-0.412
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)60.584
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)115.939
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SEA
P02766TTRTransthyretinT86462SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P23280CA6Carbonic anhydrase VIT06569SEA
P22748CA4Carbonic anhydrase IVT53378SEA
Q92731ESR2Estrogen receptor betaT80896SEA
P05186ALPLAlkaline phosphatase, tissue-nonspecific isozymeT09538SEA
P20151KLK2Kallikrein 2T01908SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P49763PGFPlacenta growth factorT70792SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T86462DI0026Amyloidosis[ICD-11: 5D00]P02766TTR
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T80896DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q92731ESR2
T80896DI0108Cushing syndrome[ICD-11: 5A70]Q92731ESR2
T80896DI0254Menopausal disorder[ICD-11: GA30]Q92731ESR2
T80896DI0432Vasomotor/allergic rhinitis[ICD-11: CA08]Q92731ESR2
T09538DI0164Genetic prion disease[ICD-11: 8E02]P05186ALPL
T09538DI0330Parasitic infection[ICD-11: 1D0Y-1G2Z]P05186ALPL
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1

Copyright © 2025